FLORHAM PARK, N.J., April 12, 2023 Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced. | April 12, 2023
Vyant Bio, Inc. (NASDAQ:NASDAQ:VYNT) Q1 2022 Earnings Conference Call May 16, 2022 04:30 PM ET Company Participants Jay Roberts - Chief Executive Officer Andy LaFrence - Chief Financial.